Costs of Type 2 Diabetes Treatment in Phukhieo Chalermprakiat Hospital

Main Article Content

Thanyaporn Kerdsak na Wangnoi
Surasak Chaiyasong
Krisanee Saramunee

Abstract

Introduction: The  objective  of  this  study  is  to  determine  cost  of  treatment  for  type  2 diabetes mellitus (T2DM) in healthcare providerzs perspective. Methods: Data of T2DM patients aged 35 years or above who received the treatment in Phukhieo Chalermphrakiat hospital during 1 October 2014  R  30  September  2015  were  retrospectively  collected  from  electronic  database.  This  study measured direct medical costs occurred at out-patient (OP) and in-patient (IP) departments including medical  service,  drug,  laboratory  test,  and  medical material  costs.  Healthcare  utilization  and  costs were described across T2DM  patient groups. Results: In fiscal year 2015,  there were 4,413  T2DM patients.  Most  of  them  were  female  (69.4%),  aged  60.6±10.5  years,  without  complication  (65.1%). Among  4,288  out-patients,  average  OP  visit  was  3.8 times/out-patient/year,  and  among  784  in- patients,  average  IP  visit  and  length  of  stay  were 1.3  times/in-patient/year  and  13.6  days/in-patient/year. Total cost of T2DM treatment was 29,315,121 baht (63.2% OP cost and 36.8% IP cost). Average OP cost was 4,321.0 baht/out-patient/year (77.4% accounted for drug cost) and average IP cost was 13,758.7  baht/in-patient/year (48.9%  accounted for medical  service cost).  For the  patients without  complication,  OP  cost  was  2,862.3±2,619.0  (median  2,312.2)  baht/out-patient/year  and  IP cost was 9,202.4±14,332.1 (median 4,236.0) baht/in-patient/year.  For the patients with  complication, OP  cost  was  6,306.0±9,013.7  (median  4,741.0)  baht/in-patient/year  and  IP  cost  was 15,609.1±26,255.1 (median 6,999.0) baht/in-patient/year. These costs were the highest in the patients with  both  micro  and  macrovascular  complications. Conclusion: Treatment  of  T2DM  is  costly  in particular patients with complication. Effective prevention and control of diabetes and its complication would reduce health burden and expenditure.

Article Details

Section
Pharmaceutical Practice

References

Burden of Disease Thailand. 2009. Report of Burden of Disease in Thailand B.E.2552. http://www.thaibod.net/th/report/category/6--2009-.htmldownload=37%3A-disability-adjusted-life-year-daly. Accessed August 3, 2015

Chaiyasong S, Rattanachotphanit R, Waleekhachonloet O, Sitthithanyakit B. Cost-Effectiveness of Alendronate and Risedronate for Primary Prevention of Fractures in Postmenopausal Women. IJPS. 2013; 9(2): 23-36.

Chatterjee S, Riewpaiboon A, Piyauthakit P, et al. Cost of diabetes and its complications in Thailand: a complete picture of economic burden. Health Soc Care Community 2011; 19(3): 289-98.

Chumnui S. Factor of Blood Sugar Level Control in Diabetic Patient Type 2 Rongkam Hospital Rongkam District Kalasin Province. Research And Development Health System Journal 2008; 1(3): 60-9.

Herman WH. The cost-effectiveness of diabetes prevention: results from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study Clinical Diabetes and Endocrinology. 20151:9 DOI: 10.1186/s40842-015-0009-1.

Institute of Health Metrics and Evaluation. 2014. Global Burden of Disease.

www.healthdata.org. Accessed Sep 5, 2015.

Javanbakht M, Baradaran HR, Mashayekhi A, et al. Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran. PLoSONE 2011;6(10):e26864. doi: 10.1371/journal.pone.0026864

Kanglee K. Factors Associated With Glycemic Control Among People With Type 2 Diabetes Millitus at Phramongkutklao Hospital, Bangkok. Journal of Royal Thai Army Nurses 2014; 15(3): 256-68.

Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review. Diabetes Care. 2010 Aug; 33(8): 1872-1894.

Phukhieo Chalermprakiat hospital. Hospital profile 2015.

Phuribancha P, Prompakdee B, Sulakan P. The Cost Effective Analysis of lifestyle Modification and Medication intervention to prevent the development of type 2 diabetes in prediabetes. Journal of Office of Disease Prevention and Control 6 Khon Kaen. 2012; 19(2): 1-16.

Reiwpaiboon A, Chatterjee S, Piyauthakit P. Cost analysis for efficient management: diabetes treatment at a public district hospital in Thailand. Int J Pharm Pract 2011; 5: 342-9.

Tantivipanuwong S. Determination of factors affecting medical expenditures of diabetes patients from electronic database (Master Thesis in Pharmacy Administration). Faculty of Graduate studies. Bangkok: Mahidol University; 2005.

World Health Organization. Global status report on noncommunicable diseases 2010. Geneva:

World Health Organization. 2011.

World Health Organization. Global action plan for the prevention and control of NCDs 2013- 2020. Geneva: World Health Organization. 2013.